Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05327894 |
| Consolidated Lead Sponsor | Princess Maxima Center for Pediatric Oncology |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 160 participants (ESTIMATED) |
| Registered Start Date | 2022-12-15 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Queensland Children's Hospital | South Brisbane, Australia | Open Hospital Dossier -> |
| Cliniques Universitaires Saint-Luc | Brussels, Belgium | Open Hospital Dossier -> |
| Universitair Ziekenhuis Gent | Ghent, Belgium | Open Hospital Dossier -> |
| UZ Leuven | Leuven, Belgium | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.